Quarterly report pursuant to Section 13 or 15(d)

Debt - Narrative (Details)

v3.20.2
Debt - Narrative (Details)
1 Months Ended 9 Months Ended 48 Months Ended
Feb. 25, 2020
USD ($)
Feb. 20, 2019
USD ($)
Jan. 30, 2013
USD ($)
Feb. 28, 2019
USD ($)
day
$ / shares
shares
Feb. 28, 2018
USD ($)
$ / shares
Nov. 30, 2015
USD ($)
Jan. 31, 2013
Sep. 30, 2020
USD ($)
institution
shares
Sep. 30, 2019
USD ($)
Dec. 31, 2016
USD ($)
shares
Dec. 31, 2019
USD ($)
institution
Feb. 01, 2019
USD ($)
Nov. 08, 2018
USD ($)
Debt Instrument [Line Items]                          
Credit line capacity               $ 100,974,000          
Repayments of lines of credit               742,932,000 $ 158,477,000        
Long-term line of credit, noncurrent               0     $ 44,749,000    
Goodwill               $ 675,795,000     $ 671,940,000    
Number of financial institutions | institution               11     11    
BioReference                          
Debt Instrument [Line Items]                          
Net assets               $ 968,000,000.0          
Goodwill               434,800,000          
Intangible assets               $ 337,100,000          
OPKO Health Europe                          
Debt Instrument [Line Items]                          
Weighted average interest rate               2.80%     2.70%    
Minimum | OPKO Health Europe                          
Debt Instrument [Line Items]                          
Variable interest rates               0.70%          
Maximum | OPKO Health Europe                          
Debt Instrument [Line Items]                          
Variable interest rates               3.80%          
Line of Credit                          
Debt Instrument [Line Items]                          
Weighted average interest rate               5.30%     4.00%    
Convertible Debt                          
Debt Instrument [Line Items]                          
Interest rate on notes payable       4.50%                  
Convertible Debt | Convertible Senior Notes Due 2025                          
Debt Instrument [Line Items]                          
Debt face amount       $ 200,000,000.0                  
Debt instrument, conversion ratio       0.2367424                  
Conversion price per share (in dollars per share) | $ / shares       $ 4.22                  
Shares issuable under debt agreement (in shares) | shares       30,000,000                  
Shares issued on converted debt (in shares) | shares               29,250,000          
Proceeds one-time nominal fee               $ 300,000          
Equity component of convertible debt       $ 52,600,000                  
Effective interest rate               11.20%          
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period one                          
Debt Instrument [Line Items]                          
Convertible debt, threshold percentage of stock price trigger       130.00%                  
Equivalent redemption price       100.00%                  
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period one | Minimum                          
Debt Instrument [Line Items]                          
Number of trading days | day       20                  
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period one | Maximum                          
Debt Instrument [Line Items]                          
Number of consecutive trading days applicable conversion price | day       30                  
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period two                          
Debt Instrument [Line Items]                          
Convertible debt, threshold percentage of stock price trigger       98.00%                  
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period two | Minimum                          
Debt Instrument [Line Items]                          
Number of trading days | day       5                  
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period two | Maximum                          
Debt Instrument [Line Items]                          
Number of consecutive trading days applicable conversion price | day       5                  
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period three                          
Debt Instrument [Line Items]                          
Convertible debt, threshold percentage of stock price trigger       130.00%                  
Equivalent redemption price       100.00%                  
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period three | Minimum                          
Debt Instrument [Line Items]                          
Number of trading days | day       20                  
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period three | Maximum                          
Debt Instrument [Line Items]                          
Number of consecutive trading days applicable conversion price | day       30                  
Convertible Debt | 5% Convertible Notes                          
Debt Instrument [Line Items]                          
Interest rate on notes payable         5.00%                
Debt face amount         $ 55,000,000.0                
Conversion price per share (in dollars per share) | $ / shares         $ 5.00                
Debt instrument, term         5 years                
Minimum conversion notice         30 days                
Maximum conversion notice         60 days                
Convertible Debt | Notes Due February 1, 2033                          
Debt Instrument [Line Items]                          
Converted debt amount                   $ 143,200,000      
Senior Notes                          
Debt Instrument [Line Items]                          
Remaining principal               $ 154,061,000     $ 148,140,000    
Senior Notes | Notes Due February 1, 2033                          
Debt Instrument [Line Items]                          
Interest rate on notes payable     3.00%                    
Debt face amount     $ 175,000,000.0                    
Equivalent redemption price     100.00%                    
Notes | Notes Due February 1, 2033                          
Debt Instrument [Line Items]                          
Equivalent redemption price             100.00%            
Debt repurchase amount                       $ 28,800,000  
Remaining principal                       $ 3,000,000.0  
Line of Credit | Unsecured Debt                          
Debt Instrument [Line Items]                          
Credit line capacity $ 100,000,000                       $ 60,000,000
Interest rate on notes payable 11.00%                       10.00%
Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Credit line capacity           $ 75,000,000.0              
Commitment fee (as a percent) 0.25%                        
Remaining borrowing capacity               64,700,000          
Commitment fee percentage           0.25%              
Long-term line of credit, noncurrent               $ 0          
Swingline | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Credit line capacity           $ 20,000,000.0              
Letter of Credit | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Credit line capacity           $ 20,000,000.0              
LIBOR | Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Basis spread on variable rate           2.50%              
LIBOR, First 12 Months | Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Basis spread on variable rate           0.35%              
LIBOR Thereafter | Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Basis spread on variable rate           0.50%              
LIBOR, First 12 Months, Adjusted for Eurocurrency Liabilities | Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Basis spread on variable rate           1.35%              
LIBOR, Thereafter, Adjusted for Eurocurrency Liabilities | Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Basis spread on variable rate           1.50%              
Common Stock | Convertible Debt | Notes Due February 1, 2033                          
Debt Instrument [Line Items]                          
Shares issued on converted debt (in shares) | shares                   21,539,873      
Dr Frost | Line of Credit | Unsecured Debt                          
Debt Instrument [Line Items]                          
Credit line capacity                         $ 60,000,000
Repayments of lines of credit   $ 28,800,000